Interventions to increase uptake of Human Papillomavirus (HPV) vaccination in minority populations: A systematic review.
Cancer prevention
Health disparities
Intervention studies
Minority population
Papillomavirus vaccine
Systematic review
Journal
Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
20
06
2020
revised:
27
06
2020
accepted:
04
07
2020
entrez:
28
7
2020
pubmed:
28
7
2020
medline:
28
7
2020
Statut:
epublish
Résumé
Minority youth represent a unique population for public health interventions given the social, economic, and cultural barriers they often face in accessing health services. Interventions to increase uptake of Human Papillomavirus (HPV) vaccination in minority youth have the potential to reduce disparities in HPV infection and HPV-related cancers. This systematic review assesses the effectiveness of interventions to increase HPV vaccine uptake, measured as vaccine series initiation and series completion, among adolescents and young adults, aged 9-26 years old, identifying as a racial and ethnic minority or sexual and gender minority (SGM) group in high-income countries. Of the 3013 citations produced by a systematic search of three electronic databases (PubMed, Embase, and Web of Science) in November 2018, nine studies involving 9749 participants were selected for inclusion. All studies were conducted in the United States and were published from 2015 to 2018. Interventions utilized education, vaccine appointment reminders, and negotiated interviewing to increase vaccination. Participants were Black or African American (44.4%), Asian (33.3%), Hispanic or Latinx (22.2%), American Indian or Alaska Native (11.1%), and SGM (22.2%). Studies enrolled parent-child dyads (33.3%), parents alone (11.1%), and youth alone (55.6%). Vaccine series initiation ranged from 11.1% to 84% and series completion ranged from 5.6% to 74.2% post-intervention. Educational and appointment reminder interventions may improve HPV vaccine series initiation and completion in minority youth in the U.S. Given the lack of high quality, adequately powered studies, further research is warranted to identify effective strategies for improving HPV vaccine uptake for minority populations.
Identifiants
pubmed: 32714778
doi: 10.1016/j.pmedr.2020.101163
pii: S2211-3355(20)30123-6
pii: 101163
pmc: PMC7372149
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
101163Subventions
Organisme : NCI NIH HHS
ID : R25 CA217725
Pays : United States
Informations de copyright
© 2020 The Authors. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Vaccine. 2020 Jan 3;38(1):39-45
pubmed: 31611099
J Adolesc Health. 2010 Dec;47(6):596-9
pubmed: 21094437
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Ann Fam Med. 2011 Jan-Feb;9(1):37-43
pubmed: 21242559
Syst Rev. 2017 Dec 06;6(1):245
pubmed: 29208034
Pediatrics. 2016 Jul;138(1):
pubmed: 27296865
J Am Coll Health. 2016 May-Jun;64(4):269-78
pubmed: 26821923
BMC Public Health. 2018 Jun 15;18(1):746
pubmed: 29907115
Hum Vaccin Immunother. 2016 Jun 2;12(6):1566-88
pubmed: 26838959
Vaccine. 2011 May 12;29(21):3767-72
pubmed: 21440038
Vaccine. 2013 Apr 12;31(16):2028-34
pubmed: 23474310
J Adolesc Health. 2004 Aug;35(2):160-7
pubmed: 15298005
Prev Med. 2010 Aug;51(2):182-4
pubmed: 20538014
Am J Prev Med. 2019 Apr;56(4):591-602
pubmed: 30773231
J Cancer Educ. 2015 Jun;30(2):353-9
pubmed: 24898942
MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):918-924
pubmed: 30138307
Clin Ther. 2014 Jan 1;36(1):24-37
pubmed: 24417783
Womens Health Issues. 2012 Nov-Dec;22(6):e571-9
pubmed: 23122214
J Adolesc Health. 2015 Jan;56(1):85-90
pubmed: 25438965
Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1463-72
pubmed: 21602307
MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):625-33
pubmed: 25055186
Hum Vaccin Immunother. 2015;11(12):2883-94
pubmed: 26378650
J Cancer Educ. 2018 Oct;33(5):1126-1131
pubmed: 28456947
Vaccine. 2014 Apr 7;32(17):1901-20
pubmed: 24530401
Pediatrics. 2011 Jan;127(1):77-84
pubmed: 21149425
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1257-61
pubmed: 16835320
Vaccine. 2018 Jun 18;36(26):3868-3875
pubmed: 29778516
Hum Vaccin Immunother. 2014;10(9):2632-5
pubmed: 25483503
J Community Health. 2016 Apr;41(2):274-81
pubmed: 26399648
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Public Health. 2017 Mar;144:86-91
pubmed: 28274389
Public Health. 2017 Jan;142:167-176
pubmed: 27592005
J Pediatr Adolesc Gynecol. 2015 Feb;28(1):19-23
pubmed: 25444051
LGBT Health. 2018 Jul;5(5):325-329
pubmed: 29979642
Clin Pediatr (Phila). 2013 Mar;52(3):231-40
pubmed: 23362316
J Pediatr. 2010 Oct;157(4):617-22
pubmed: 20472250
J Cancer Educ. 2019 Feb;34(1):66-72
pubmed: 28808906
Appl Nurs Res. 2018 Apr;40:51-60
pubmed: 29579499
MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702
pubmed: 31415491
MMWR Morb Mortal Wkly Rep. 2015 Mar 27;64(11):300-4
pubmed: 25811679
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Vaccine. 2018 Aug 9;36(33):5065-5070
pubmed: 30037419
Cochrane Database Syst Rev. 2018 Jan 18;1:CD003941
pubmed: 29342498
Acta Cytol. 2016;60(6):518-526
pubmed: 27825171
Clin Pediatr (Phila). 2016 Aug;55(9):851-9
pubmed: 26968631
Prev Med. 2019 Jun;123:197-203
pubmed: 30930259